$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Sustained pulsewise release pharmaceutical preparation 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-002/00
출원번호 US-0946158 (1986-12-23)
우선권정보 JP-0297550 (1985-12-28); JP-0272542 (1986-11-14)
발명자 / 주소
  • Fujioka Keiji (Ibaraki JPX) Sato Shigeji (Ibaraki JPX) Takada Yoshihiro (Ibaraki JPX) Sasaki Yoshio (Ibaraki JPX) Tamura Nobuhiko (Ibaraki JPX)
출원인 / 주소
  • Sumitomo Pharmaceuticals Company, Limited (Osaka JPX 03)
인용정보 피인용 횟수 : 150  인용 특허 : 7

초록

The invention relates to sustained pulsewise release pharmaceutical preparation which comprices drug-containing polymeric material layers (layers A) and polymeric material layers containing the drug in question only in a slight amount or free of the drug (layers B) disposed alternatingly, with the w

대표청구항

A sustained pulsewise-release pharmaceutical dosage form means for embedding beneath skin which embedded administration comprises (a) drug-containing polymeric material layers (layers A) and polymeric material layers free from the drug in question or containing only a slight and significantly smalle

이 특허에 인용된 특허 (7)

  1. Zaffaroni Alejandro (Atherton CA) Wong Patrick S. L. (Hayward CA), Active agent dispenser.
  2. DePrince Randolph B. (Terre Haute IN), Disc-like sustained release formulation.
  3. Deters Joseph C. (Mountain View CA) Theeuwes Felix (Los Altos CA) Mullins Kevin J. (Berkeley CA) Eckenhoff James B. (Los Altos CA), Osmotic capsule.
  4. Higuchi Takeru (Lawrence KS), Osmotic drug delivery system.
  5. Kaetsu Isao (Takasaki JPX) Yoshida Masaru (Takasaki JPX), Process for producing a multi-layered slow release composite.
  6. Bruck, Stephen D., Rate-controlled drug release system.
  7. Theeuwes Felix (Los Altos CA), System with microporous reservoir having surface for diffusional delivery of agent.

이 특허를 인용한 특허 (150)

  1. Knight, James; Cartt, Steve; Young, David; Becker, Patrice, ACTH for treatment of acute respiratory distress syndrome.
  2. Cartt, Steve; Gong, Rujun, ACTH prophylactic treatment of renal disorders.
  3. Cartt, Steve; Gong, Rujun, ACTH prophylactic treatment of renal disorders.
  4. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  5. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  6. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  7. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  8. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  9. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  10. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  11. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  12. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  13. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  14. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  15. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  16. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Amoxicillin-clarithromycin antibiotic composition.
  17. Rudnic, Edward M.; Isbiter, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Amoxicillin-dicloxacillin antibiotic composition.
  18. Chen, Isan; Hager, Jeffrey H; Maneval, Edna Chow; Herbert, Mark R; Smith, Nicholas D, Androgen receptor modulator and uses thereof.
  19. Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D., Androgen receptor modulators and uses thereof.
  20. Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D., Androgen receptor modulators and uses thereof.
  21. Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D., Androgen receptor modulators and uses thereof.
  22. Chen, Isan, Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer.
  23. Chen, Isan, Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer.
  24. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Anti-fungal composition.
  25. Rudnic,Edward M., Antibiotic composition with inhibitor.
  26. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  27. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  28. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  29. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  30. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  31. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  32. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  33. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic product, use and formulation thereof.
  34. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic product, use and formulation thereof.
  35. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Antiviral product, use and formulation thereof.
  36. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Antiviral product, use and formulation thereof.
  37. Hair, Gregory A.; Boden, Scott D., Bone mineralization proteins, DNA, vectors expression systems.
  38. Gregory A. Hair ; Scott D. Boden, Bone mineralization proteins, DNA, vectors, expression systems.
  39. Hair Gregory A. ; Boden Scott D., Bone mineralization proteins, DNA, vectors, expression systems.
  40. Hair, Gregory A.; Boden, Scott D., Bone mineralization proteins, DNA, vectors, expression systems.
  41. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Cephalosporin-metronidazole antibiotic composition.
  42. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Ciprofoxacin-metronidazole antibiotic composition.
  43. Jill K. Sherwood ; Linda G. Griffith ; Scott Brown, Composites for tissue regeneration and methods of manufacture thereof.
  44. Baird, Andrew; Gonzalez, Ana Maria; Logan, Ann; Berry, Martin, Compositions and methods for delivery of agents for neuronal regeneration and survival.
  45. Flanner, Henry H.; Guttendorf, Robert J.; Clausen, Susan P.; Treacy, Donald; Burnside, Beth A., Compositions and methods for improved efficacy of penicillin-type antibiotics.
  46. Tseng, Scheffer; He, Hua, Compositions containing HC-HA complex and methods of use thereof.
  47. Tseng, Scheffer; He, Hua; Tighe, Sean; Zhang, Suzhen; Zhu, Ying-Tieng, Compositions containing HC-HA/PTX3 complexes and methods of use thereof.
  48. Tseng, Scheffer; He, Hua; Tighe, Sean; Zhang, Suzhen; Zhu, Ying-Tieng, Compositions containing HC-HA/PTX3 complexes and methods of use thereof.
  49. Tseng, Scheffer; Chua, Lorraine, Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof.
  50. Simon, Julian; Johnson, Graham; Rubel, Edwin; Raible, David; Gonzalez, Mario D.; Meltzer, Peter C.; Miao, Weishi, Compounds and methods for preventing or treating sensory hair cell death.
  51. Simon, Julian; Johnson, Graham; Rubel, Edwin; Chowdhury, Sarwat; Herr, R. Jason; Jiang, Qin; Chen, Xinchao; Owens, Kelly N.; Raible, David, Compounds and methods for preventing, treating and/or protecting against sensory hair cell death.
  52. Simon, Julian; Johnson, Graham; Rubel, Edwin; Chowdhury, Sarwat; Herr, R. Jason; Jiang, Qin; Chen, Xinchao; Owens, Kelly N; Raible, David, Compounds and methods for preventing, treating and/or protecting against sensory hair cell death.
  53. Cao, Jianguo; Wang, Zhijun; Grey, Jonathan; Rogers, Evan; Whitten, Jeffrey P., Compounds that modulate intracellular calcium.
  54. Rogers, Evan; Cao, Jianguo; Wang, Zhijun; Grey, Jonathan; Whitten, Jeffrey P., Compounds that modulate intracellular calcium.
  55. Cardamone Michael,AUX ; Bentley Herbert William,AUX, Controlled release device and method.
  56. Crison, John R.; Amidon, Gordon L., Controlled release of drugs.
  57. Sano,Akihiko; Kajihara,Masako; Sugie,Toshihiko, Controlled release preparations having multi-layer structure.
  58. Ma, Peter X.; Liu, Xiaohua; McCauley, Laurie, Delivery device and method for forming the same.
  59. Monkhouse, Donald; Yoo, Jaedeok; Sherwood, Jill K.; Cima, Michael J.; Bornancini, Esteban, Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof.
  60. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Erythromyacin antibiotic product, use and formulation thereof.
  61. Venkatesh, Gopi M.; Vishnupad, Krishna S.; Percel, Phillip J., Extended release dosage forms of propranolol hydrochloride.
  62. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  63. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  64. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  65. Leonard, Edward F.; Reich, Ilan K.; Cortell, Stanley, Fluid separation devices, systems and methods.
  66. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Fluroquinilone antibiotic product, use and formulation thereof.
  67. Kumar, Ravi Seshagirirao, Formulations and methods for treatment of metabolic syndrome.
  68. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram, Formulations of histone deacetylase inhibitor and uses thereof.
  69. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram, Formulations of histone deacetylase inhibitor and uses thereof.
  70. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram, Formulations of histone deacetylase inhibitor and uses therof.
  71. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram; Kloos, Ioana; Depil, Stephane, Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof.
  72. Bonadio Jeffrey ; Goldstein Steven A., Gene transfer into bone cells and tissues.
  73. Shalaby Shalaby W. (Anderson SC), Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof.
  74. Shalaby W. Shalaby, Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof.
  75. Rothen-Weinhold Alexandra,CHX ; Gurny Robert,CHX ; Orsolini Piero,CHX ; Heimgartner Frederic,CHX, Implants for controlled release of pharmaceutically active principles and method for making same.
  76. Goldstein Steven A. ; Bonadio Jeffrey, In vivo gene transfer methods for wound healing.
  77. Beaton, Graham; Tucci, Fabio; Ravula, Satheesh B.; Wang, Hua-Yu, Inhibition of OLIG2 activity.
  78. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  79. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  80. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  81. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Levofloxacin antibiotic product, use and formulation thereof.
  82. Sano, Akihiko; Maeda, Hiroo; Kajihara, Masako; Tani, Shunsuke; Sugie, Toshihiko, Long time drug-sustained release preparation.
  83. Brazeau Paul,CAX ; Abribat Thierry,CAX ; Ibea Michel,CAX, Long-acting galenical formulation for GRF peptides.
  84. Brazeau Paul,CAX ; Gravel Denis,CAX, Long-acting galenical formulation for GRF peptides.
  85. Adimoolam, Shanthi; Buggy, Joseph J.; Magda, Darren; Miller, Richard, Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy.
  86. Bonadio Jeffrey ; Goldstein Steven A., Methods and compositions for multiple gene transfer into bone cells.
  87. Rutherford,Bruce; Somogyi,Christopher; White,Clinton; Rabins,Erick, Methods for treating dental conditions using tissue scaffolds.
  88. Leonard, Edward F.; West, Alan C.; Shapley, Nina C.; Tang, Zhongliang, Methods of blood-based therapies having a microfluidic membraneless exchange device.
  89. Tseng, Scheffer; Tan, Ek Kia; He, Hua, Methods of modulating bone remodeling.
  90. Tseng, Scheffer; Tan, Ek Kia; He, Hua, Methods of modulating bone remodeling.
  91. Tseng, Scheffer; Tan, Ek Kia; Chua, Lorraine, Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof.
  92. Lee, Ronald D.; Vakily, Majid; Mulford, Darcy; Wu, Jing-Tao; Atkinson, Stuart, Methods of treating gastrointestinal disorders independent of the intake of food.
  93. Bonadio, Jeffrey; Yin, Wushan, Methods of using latent TGF-β binding proteins.
  94. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Metronidazole antibiotic product, use and formulation thereof.
  95. Flanner, Henry H.; Tolle-Sander, Sanna; Treacy, Donald; Burnside, Beth A.; Clausen, Susan P., Modified release amoxicillin products.
  96. Shalaby, Shalaby W.; Shalaby, Waleed S. W.; Shalaby, Marc, Multifaceted compositions for post-surgical adhesion prevention.
  97. Taneja, Rajneesh; Vakilynejad, Majid, Multiple PPI dosage form.
  98. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed release anti-neoplastic product, use and formulation thereof.
  99. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed release anti-viral product, use and formulation thereof.
  100. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed release antifungal product, use and formulation thereof.
  101. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed released antibiotic product, use and formulation thereof.
  102. Rudnic, Edward M; Isbister, James D; Treacy, Jr., Donald J; Wassink, Sandra E, Once a day amoxicillin product comprising immediate and delayed release dosage forms.
  103. Kamal K. Midha BM; Mark Hirsh ; Whe-Yong Lo, Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent.
  104. Midha, Kamal K.; Hirsh, Mark; Lo, Whe-Yong, Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent.
  105. Burnside Beth A. ; Guo Xiaodi ; Fiske Kimberly ; Couch Richard A. ; Treacy Donald J. ; Chang Rong-Kun ; McGuinness Charlotte ; Rudnic Edward M., Oral pulsed dose drug delivery system.
  106. Burnside, Beth A.; Guo, Xiaodi; Fiske, Kimberly; Couch, Richard A.; Chang, Rong-Kun; Treacy, Donald J.; McGuiness, Charlotte M.; Rudnic, Edward M., Oral pulsed dose drug delivery system.
  107. Burnside, Beth A.; Guo, Xiaodi; Fiske, Kimberly; Couch, Richard A.; Treacy, Donald J.; Chang, Rong-Kun; McGuinness, Charlotte M.; Rudnic, Edward M., Oral pulsed dose drug delivery system.
  108. Burnside, Beth A.; Guo, Xiaodi; Fiske, Kimberly; Couch, Richard A.; Treacy, Donald J.; Chang, Rong-Kun; Rudnic, Edward M.; McGuinness, Charlotte M., Oral pulsed dose drug delivery system.
  109. Venkatesh, Gopi M.; Harmon, Troy M.; Taylor, John, Orally disintegrating tablets of atomoxetine.
  110. Stappenbeck, Frank; Fan, Yi Chiao, Oxysterols and hedgehog signaling.
  111. Flanner, Henry H.; Guttendorf, Robert; Treacy, Donald; Clausen, Susan P.; Burnside, Beth A., Pharmaceutical compositions and methods for improved bacterial eradication.
  112. Totakura Nagabhushanam ; Muth Ross R. ; Gravener Roy D. ; Hain Matthew ; Koyfman Ilya S., Post-surgical anti-adhesion device.
  113. Cima Linda G. ; Cima Michael J., Preparation of medical devices by solid free-form fabrication methods.
  114. Loughman, Thomas Ciaran, Process for making absorbable microparticles.
  115. Percel, Philip J.; Vyas, Nehal H.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Pulsatile release histamine H2 antagonist dosage form.
  116. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  117. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  118. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  119. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  120. Chen, Wei; Loury, David J., Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors.
  121. Bonadio Jeffrey ; Yin Wushan, Recombinant production of latent TGF-beta binding protein-3 (LTBP-3).
  122. Cao, Bruce X.; Burnside, Beth A.; Wassink, Sandra E.; Baker, Matt R., Robust pellet.
  123. Barr Ian G. (Parkville AUX) Thiel William J. (Parkville AUX), Single dose vaccination system.
  124. Andrew W. Buirge ; Paul J. Buscemi ; Paul H. Burmeister, Stent with collagen.
  125. Couch, Richard A.; Burnside, Beth A.; Chang, Rong-Kun, Sustained release delivery of amphetamine salts.
  126. Leonard, Edward F.; West, Alan C.; Shapley, Nina C.; Tang, Zhongliang, Systems and methods for membraneless dialysis.
  127. Leonard, Edward F.; West, Alan C.; Shaplely, Nina C.; Tang, Zhongliang, Systems and methods of blood-based therapies having a microfluidic membraneless exchange device.
  128. Leonard, Edward F.; West, Alan C.; Shapley, Nina C.; Tang, Zhongliang, Systems and methods of blood-based therapies having a microfluidic membraneless exchange device.
  129. Leonard, Edward F.; West, Alan C.; Aucoin, Christian P.; Nanne, Edgar E., Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams.
  130. Leonard, Edward F.; West, Alan C.; Aucoin, Christian Paul; Nanne, Edgar E., Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams.
  131. Leonard, Edward F.; West, Alan C.; Aucoin, Christian Paul; Nanne, Edgar E., Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams.
  132. Leonard, Edward F.; West, Alan C.; Aucoin, Christian Paul; Nanne, Edgar E., Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams.
  133. Leonard, Edward F.; West, Alan C.; Aucoin, Christian Paul; Nanne, Edgar E., Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams.
  134. Leonard, Edward F.; West, Alan C.; Aucoin, Christian Paul; Nanne, Edgar E., Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams.
  135. Cao, Bruce; Wassink, Sandra E.; Treacy, Jr., Donald J.; Burnside, Beth A.; Rowlings, Colin E.; Bonck, John A., Tablet for pulsed delivery.
  136. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  137. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  138. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Tetracycline antibiotic product, use and formulation thereof.
  139. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Tetracycline--doxycycline antibiotic composition.
  140. Percel, Phillip; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed pulsatile drug delivery systems.
  141. Percel,Phillip J.; Vishnupad,Krishna S.; Venkatesh,Gopi M.; Lee,Der Yang, Timed pulsatile drug delivery systems.
  142. Venkatesh, Gopi M., Timed, pulsatile release systems.
  143. Venkatesh, Gopi M., Timed, pulsatile release systems.
  144. Venkatesh, Gopi M., Timed, pulsatile release systems.
  145. Venkatesh, Gopi M., Timed, pulsatile release systems.
  146. Venkatesh, Gopi M., Timed, pulsatile release systems.
  147. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
  148. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
  149. Phillip J. Percel ; Krishna S. Vishnupad ; Gopi M. Venkatesh, Timed, sustained release systems for propranolol.
  150. Cima, Linda G.; Cima, Michael J., Tissue regeneration matrices by solid free-form fabrication techniques.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로